Baxter International Inc
BAX
Company Profile
Business description
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.
Contact
One Baxter Parkway
DeerfieldIL60015
USAT: +1 224 948-2000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2024
Employees
60,000
Baxter International Inc News & Analysis
stocks
10 cheap US dividend-growth stocks to buy
The stocks of these companies with a history of dividend increases look undervalued today.
stocks
6 undervalued stocks with low beta
Berkshire Hathaway and Verizon are among the low-volatility stocks that trade at a discount.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,567.00 | 12.10 | -0.14% |
| CAC 40 | 7,213.32 | 14.87 | 0.21% |
| DAX 40 | 19,146.17 | 141.39 | 0.74% |
| Dow JONES (US) | 43,792.38 | 383.91 | 0.88% |
| FTSE 100 | 8,149.27 | 64.20 | 0.79% |
| HKSE | 19,601.11 | 103.90 | -0.53% |
| NASDAQ | 18,930.80 | 35.34 | -0.19% |
| Nikkei 225 | 38,026.17 | 326.17 | -0.85% |
| NZX 50 Index | 12,765.24 | 28.18 | 0.22% |
| S&P 500 | 5,936.57 | 19.46 | 0.33% |
| S&P/ASX 200 | 8,323.00 | 3.30 | -0.04% |
| SSE Composite Index | 3,370.40 | 2.41 | 0.07% |